118 related articles for article (PubMed ID: 11524665)
1. The C-terminus of p53: the more you learn the less you know.
Ahn J; Prives C
Nat Struct Biol; 2001 Sep; 8(9):730-2. PubMed ID: 11524665
[No Abstract] [Full Text] [Related]
2. Latent and active p53 are identical in conformation.
Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
[TBL] [Abstract][Full Text] [Related]
3. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding.
Rippin TM; Freund SM; Veprintsev DB; Fersht AR
J Mol Biol; 2002 May; 319(2):351-8. PubMed ID: 12051912
[TBL] [Abstract][Full Text] [Related]
4. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.
Petros AM; Gunasekera A; Xu N; Olejniczak ET; Fesik SW
FEBS Lett; 2004 Feb; 559(1-3):171-4. PubMed ID: 14960327
[TBL] [Abstract][Full Text] [Related]
5. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
[TBL] [Abstract][Full Text] [Related]
6. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
[TBL] [Abstract][Full Text] [Related]
7. Cooperative binding of p53 to DNA: regulation by protein-protein interactions through a double salt bridge.
Dehner A; Klein C; Hansen S; Müller L; Buchner J; Schwaiger M; Kessler H
Angew Chem Int Ed Engl; 2005 Aug; 44(33):5247-51. PubMed ID: 16035029
[No Abstract] [Full Text] [Related]
8. Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
Pivonková H; Brázdová M; Kaspárková J; Brabec V; Fojta M
Biochem Biophys Res Commun; 2006 Jan; 339(2):477-84. PubMed ID: 16300733
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
10. Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
Rustandi RR; Baldisseri DM; Weber DJ
Nat Struct Biol; 2000 Jul; 7(7):570-4. PubMed ID: 10876243
[TBL] [Abstract][Full Text] [Related]
11. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.
Sachchidanand ; Resnick-Silverman L; Yan S; Mutjaba S; Liu WJ; Zeng L; Manfredi JJ; Zhou MM
Chem Biol; 2006 Jan; 13(1):81-90. PubMed ID: 16426974
[TBL] [Abstract][Full Text] [Related]
12. The complex interactions of p53 with target DNA: we learn as we go.
Kim E; Deppert W
Biochem Cell Biol; 2003 Jun; 81(3):141-50. PubMed ID: 12897847
[TBL] [Abstract][Full Text] [Related]
13. Structure of the human p53 core domain in the absence of DNA.
Wang Y; Rosengarth A; Luecke H
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the p53-rescue drug CP-31398 in vitro and in living cells.
Rippin TM; Bykov VJ; Freund SM; Selivanova G; Wiman KG; Fersht AR
Oncogene; 2002 Mar; 21(14):2119-29. PubMed ID: 11948395
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
Xu H; Tai J; Ye H; Kang CB; Yoon HS
Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
[TBL] [Abstract][Full Text] [Related]
16. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation.
Lambert B; Buckle M
FEBS Lett; 2006 Jan; 580(1):345-50. PubMed ID: 16376884
[TBL] [Abstract][Full Text] [Related]
18. The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage.
Okorokov AL; Rubbi CP; Metcalfe S; Milner J
Oncogene; 2002 Jan; 21(3):356-67. PubMed ID: 11821948
[TBL] [Abstract][Full Text] [Related]
19. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
20. The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.
Okorokov AL; Sherman MB; Plisson C; Grinkevich V; Sigmundsson K; Selivanova G; Milner J; Orlova EV
EMBO J; 2006 Nov; 25(21):5191-200. PubMed ID: 17053786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
